Overview
- 4 public-safe observations are available for this inspection.
- 4 structured CFR citations are represented.
- 3 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
20 Nov 2019
21 CFR 56.109(b)
Information given to subjects
Cited by Ronda R Loyd Jones, Marilyn S Babu, Mendoza O Wallace
20 Nov 2019
21 CFR 56.115(a)(2)
Minutes of IRB meetings
Cited by Ronda R Loyd Jones, Marilyn S Babu, Mendoza O Wallace
20 Nov 2019
21 CFR 56.115(a)(3)
Records of continuing review
Cited by Ronda R Loyd Jones, Marilyn S Babu, Mendoza O Wallace
20 Nov 2019
21 CFR 56.115(a)(6)
Written procedures per 56.108(a) and (b)
Cited by Ronda R Loyd Jones, Marilyn S Babu, Mendoza O Wallace
Inspected site
NMNaval Medical Center San Diego MammographySan Diego, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 56.109(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 56.115(a)(2) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 56.115(a)(3) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 56.115(a)(6) | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 4 observations
The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere